Carl Borrebaeck
51 – 60 of 322
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Expanded clinical and experimental use of SOX11-using a monoclonal antibody
(
- Contribution to journal › Article
-
Mark
Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?
(
- Contribution to journal › Article
-
Mark
Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry.
(
- Contribution to journal › Article
-
Mark
Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles.
(
- Contribution to journal › Article
-
Mark
Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties.
(
- Contribution to journal › Article
-
Mark
Serum proteome profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures
(
- Contribution to journal › Article
-
Mark
Identification of serum biomarker signatures associated with pancreatic cancer
(
- Contribution to journal › Article
- 2011
-
Mark
A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests
(
- Contribution to journal › Article
-
Mark
Histamine H(4) receptor antagonism inhibits allergen-specific T-cell responses mediated by human dendritic cells.
(
- Contribution to journal › Article
-
Mark
The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
(
- Contribution to journal › Article